These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

405 related items for PubMed ID: 6299858

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Preventative vaccination against EHV (equine herpesvirus) abortion].
    Becker W.
    Tierarztl Prax; 1988; 16(1):61-3. PubMed ID: 2835828
    [Abstract] [Full Text] [Related]

  • 3. Viraemia and abortions are not prevented by two commercial equine herpesvirus-1 vaccines after experimental challenge of horses.
    Bürki F, Rossmanith W, Nowotny N, Pallan C, Möstl K, Lussy H.
    Vet Q; 1990 Apr; 12(2):80-6. PubMed ID: 2163560
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Equine herpesvirus 1 infection in mares vaccinated with a live-virus rhinopneumonitis vaccine attenuated in cell culture.
    Eaglesome MD, Henry JN, McKnight JD.
    Can Vet J; 1979 May; 20(5):145-7. PubMed ID: 226261
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Trials of an inactivated equid herpesvirus 1 vaccine: challenge with a subtype 1 virus.
    Burrows R, Goodridge D, Denyer MS.
    Vet Rec; 1984 Apr 14; 114(15):369-74. PubMed ID: 6328728
    [Abstract] [Full Text] [Related]

  • 9. [Year-round antibody profile of groups of horses of a herd kept in isolation after differently terminating use of an experimental viral combination vaccine].
    Bürki F, Nowotny N, Hofer A.
    Dtsch Tierarztl Wochenschr; 1991 Mar 14; 98(3):82-9. PubMed ID: 1646100
    [Abstract] [Full Text] [Related]

  • 10. Immunologic relationships between equine herpesvirus type 1 (equine abortion virus) and type 4 (equine rhinopneumonitis virus).
    Fitzpatrick DR, Studdert MJ.
    Am J Vet Res; 1984 Oct 14; 45(10):1947-52. PubMed ID: 6208822
    [Abstract] [Full Text] [Related]

  • 11. Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination.
    Minke JM, Fischer L, Baudu P, Guigal PM, Sindle T, Mumford JA, Audonnet JC.
    Vet Immunol Immunopathol; 2006 May 15; 111(1-2):47-57. PubMed ID: 16580075
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Serologic responses of pregnant thoroughbred mares to vaccination with an inactivated equine herpesvirus 1 vaccine.
    Bryans JT.
    Am J Vet Res; 1980 Nov 15; 41(11):1743-6. PubMed ID: 6259970
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Equine herpesvirus.
    Vet Rec; 1989 May 13; 124(19):519. PubMed ID: 2547266
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy and duration of immunity of a combined equine influenza and equine herpesvirus vaccine against challenge with an American-like equine influenza virus (A/equi-2/Kentucky/95).
    Heldens JG, Pouwels HG, van Loon AA.
    Vet J; 2004 Mar 13; 167(2):150-7. PubMed ID: 14975389
    [Abstract] [Full Text] [Related]

  • 19. The equine immune response to equine herpesvirus-1: the virus and its vaccines.
    Kydd JH, Townsend HG, Hannant D.
    Vet Immunol Immunopathol; 2006 May 15; 111(1-2):15-30. PubMed ID: 16476492
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.